Project

Microneedle vaccination using intradermal injection method for pets

Project Summary

QuadMedicine develop microneedle suitable to deliver proprietary ingredients including vaccines for pets. Our microneedle technology enables stable and accurate delivery of quantified amount of medicines into a skin. Using this innovative technology, we can provide 1)painless administration, 2)ease of use, 3)importing substitution effect, 4) elimination of dependence on the cold chain (enabling the distribution at room temperature) to the current companion animal vaccines market. Through this technology, we will eventually lead the intradermal DDS industry.

Business Model

CRMO(Contract Research & Manufacturing Organization)

Main Achievements

- securing a new H3N2 antigen, prototype of H3N2 influenza vaccine microneedle, and GMP facility including a clean room system for manufacturing
- have verified the effectiveness by small animal experiments
- have registered patent Kor(4)/ Applied patent Kor(1), Overseas(2)/ Registered trademark Kor(2)